annual EBIT:
$11.11B+$7.85B(+240.19%)Summary
- As of today (April 12, 2025), PFE annual earnings before interest & taxes is $11.11 billion, with the most recent change of +$7.85 billion (+240.19%) on December 1, 2024.
- During the last 3 years, PFE annual EBIT has fallen by -$14.49 billion (-56.59%).
- PFE annual EBIT is now -69.10% below its all-time high of $35.97 billion, reached on December 31, 2022.
Performance
PFE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$729.00M-$4.77B(-86.74%)Summary
- As of today (April 12, 2025), PFE quarterly earnings before interest & taxes is $729.00 million, with the most recent change of -$4.77 billion (-86.74%) on December 1, 2024.
- Over the past year, PFE quarterly EBIT has stayed the same.
- PFE quarterly EBIT is now -93.79% below its all-time high of $11.74 billion, reached on June 1, 2022.
Performance
PFE quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$11.11B+$4.17B(+60.06%)Summary
- As of today (April 12, 2025), PFE TTM earnings before interest & taxes is $11.11 billion, with the most recent change of +$4.17 billion (+60.06%) on December 1, 2024.
- Over the past year, PFE TTM EBIT has stayed the same.
- PFE TTM EBIT is now -69.10% below its all-time high of $35.97 billion, reached on December 31, 2022.
Performance
PFE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PFE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +240.2% | 0.0% | 0.0% |
| 3 y3 years | -56.6% | 0.0% | 0.0% |
| 5 y5 years | -13.8% | 0.0% | 0.0% |
PFE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -69.1% | +240.2% | -93.8% | +121.2% | -69.1% | +1016.9% |
| 5 y | 5-year | -69.1% | +240.2% | -93.8% | +121.2% | -69.1% | +1016.9% |
| alltime | all time | -69.1% | +1233.4% | -93.8% | +108.2% | -69.1% | +569.7% |
Pfizer EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $11.11B(+240.2%) | $729.00M(-86.7%) | $11.11B(+60.1%) |
| Sep 2024 | - | $5.50B(+714.5%) | $6.94B(-672.9%) |
| Jun 2024 | - | $675.00M(-84.0%) | -$1.21B(-236.2%) |
| Mar 2024 | - | $4.21B(-222.4%) | $890.00M(-72.8%) |
| Dec 2023 | $3.27B(-90.9%) | -$3.44B(+29.5%) | $3.27B(-73.3%) |
| Sep 2023 | - | -$2.66B(-195.7%) | $12.25B(-49.4%) |
| Jun 2023 | - | $2.78B(-57.8%) | $24.22B(-27.0%) |
| Mar 2023 | - | $6.59B(+18.8%) | $33.18B(-7.7%) |
| Dec 2022 | $35.97B(+40.5%) | $5.54B(-40.5%) | $35.97B(+4.1%) |
| Sep 2022 | - | $9.31B(-20.7%) | $34.57B(+3.4%) |
| Jun 2022 | - | $11.74B(+25.3%) | $33.42B(+15.5%) |
| Mar 2022 | - | $9.37B(+126.2%) | $28.95B(+13.1%) |
| Dec 2021 | $25.60B(+201.7%) | $4.14B(-49.3%) | $25.60B(+14.3%) |
| Sep 2021 | - | $8.17B(+12.4%) | $22.41B(+47.9%) |
| Jun 2021 | - | $7.26B(+20.5%) | $15.15B(+34.3%) |
| Mar 2021 | - | $6.03B(+537.9%) | $11.28B(+33.0%) |
| Dec 2020 | $8.48B(-34.2%) | $945.00M(+3.3%) | $8.48B(+9766.3%) |
| Sep 2020 | - | $915.00M(-73.0%) | $86.00M(-99.2%) |
| Jun 2020 | - | $3.39B(+5.0%) | $10.31B(-9.9%) |
| Mar 2020 | - | $3.23B(-143.4%) | $11.44B(-11.3%) |
| Dec 2019 | $12.89B(+162.6%) | -$7.45B(-166.9%) | $12.90B(+12.3%) |
| Sep 2019 | - | $11.14B(+145.8%) | $11.48B(+137.5%) |
| Jun 2019 | - | $4.53B(-3.3%) | $4.83B(-6.3%) |
| Mar 2019 | - | $4.68B(-152.8%) | $5.16B(+5.0%) |
| Dec 2018 | $4.91B(-63.8%) | -$8.87B(-297.6%) | $4.91B(-67.4%) |
| Sep 2018 | - | $4.49B(-7.5%) | $15.06B(+4.0%) |
| Jun 2018 | - | $4.85B(+9.4%) | $14.48B(+5.3%) |
| Mar 2018 | - | $4.44B(+245.6%) | $13.75B(+1.3%) |
| Dec 2017 | $13.57B(+42.3%) | $1.28B(-67.1%) | $13.58B(+1.6%) |
| Sep 2017 | - | $3.90B(-5.4%) | $13.37B(+17.7%) |
| Jun 2017 | - | $4.13B(-3.1%) | $11.36B(+14.4%) |
| Mar 2017 | - | $4.26B(+297.0%) | $9.93B(+4.1%) |
| Dec 2016 | $9.54B(-6.2%) | $1.07B(-43.4%) | $9.54B(+12.9%) |
| Sep 2016 | - | $1.90B(-29.9%) | $8.45B(-11.3%) |
| Jun 2016 | - | $2.70B(-30.1%) | $9.53B(-10.5%) |
| Mar 2016 | - | $3.87B(<-9900.0%) | $10.64B(+4.7%) |
| Dec 2015 | $10.16B(-25.3%) | -$19.00M(-100.6%) | $10.16B(-17.6%) |
| Sep 2015 | - | $2.98B(-22.1%) | $12.34B(-7.2%) |
| Jun 2015 | - | $3.82B(+12.6%) | $13.29B(-3.8%) |
| Mar 2015 | - | $3.39B(+57.3%) | $13.82B(+1.6%) |
| Dec 2014 | $13.60B(-20.6%) | $2.16B(-45.1%) | $13.60B(-8.4%) |
| Sep 2014 | - | $3.93B(-9.6%) | $14.85B(+0.1%) |
| Jun 2014 | - | $4.35B(+37.2%) | $14.84B(-8.4%) |
| Mar 2014 | - | $3.17B(-7.0%) | $16.20B(-5.4%) |
| Dec 2013 | $17.13B(+34.2%) | $3.41B(-12.9%) | $17.13B(+5.9%) |
| Sep 2013 | - | $3.91B(-31.5%) | $16.17B(+4.7%) |
| Jun 2013 | - | $5.71B(+39.5%) | $15.45B(+8.1%) |
| Mar 2013 | - | $4.10B(+67.2%) | $14.29B(+9.8%) |
| Dec 2012 | $12.76B(-3.0%) | $2.45B(-23.1%) | $13.02B(+5.9%) |
| Sep 2012 | - | $3.19B(-30.1%) | $12.30B(-5.9%) |
| Jun 2012 | - | $4.56B(+61.3%) | $13.07B(+5.4%) |
| Mar 2012 | - | $2.83B(+63.5%) | $12.40B(-5.7%) |
| Dec 2011 | $13.16B(+16.8%) | $1.73B(-56.4%) | $13.15B(+2.2%) |
| Sep 2011 | - | $3.96B(+2.0%) | $12.87B(+19.8%) |
| Jun 2011 | - | $3.88B(+8.6%) | $10.74B(-3.8%) |
| Mar 2011 | - | $3.58B(+148.2%) | $11.17B(-0.8%) |
| Dec 2010 | $11.27B(-6.6%) | $1.44B(-21.7%) | $11.27B(+9.5%) |
| Sep 2010 | - | $1.84B(-57.3%) | $10.29B(-19.5%) |
| Jun 2010 | - | $4.32B(+17.5%) | $12.79B(+6.1%) |
| Mar 2010 | - | $3.67B(+684.4%) | $12.06B(-5.4%) |
| Dec 2009 | $12.06B(+18.1%) | $468.00M(-89.2%) | $12.74B(+10.7%) |
| Sep 2009 | - | $4.34B(+21.2%) | $11.52B(+4.7%) |
| Jun 2009 | - | $3.58B(-17.8%) | $11.00B(+3.7%) |
| Mar 2009 | - | $4.36B(-673.3%) | $10.61B(+5.5%) |
| Dec 2008 | $10.21B(-1.2%) | -$760.00M(-119.9%) | $10.05B(-24.9%) |
| Sep 2008 | - | $3.82B(+19.7%) | $13.39B(+28.8%) |
| Jun 2008 | - | $3.19B(-16.0%) | $10.40B(+10.7%) |
| Mar 2008 | - | $3.80B(+47.5%) | $9.39B(-9.2%) |
| Dec 2007 | $10.34B(-27.6%) | $2.58B(+210.0%) | $10.34B(-0.2%) |
| Sep 2007 | - | $831.00M(-61.9%) | $10.36B(-22.7%) |
| Jun 2007 | - | $2.18B(-54.0%) | $13.39B(-9.0%) |
| Mar 2007 | - | $4.75B(+82.7%) | $14.71B(+3.0%) |
| Dec 2006 | $14.28B(+0.5%) | $2.60B(-32.8%) | $14.28B(-5.4%) |
| Sep 2006 | - | $3.87B(+10.3%) | $15.10B(+2.1%) |
| Jun 2006 | - | $3.50B(-18.7%) | $14.78B(+1.8%) |
| Mar 2006 | - | $4.31B(+26.4%) | $14.52B(+1.0%) |
| Dec 2005 | $14.21B(-13.5%) | $3.41B(-4.0%) | $14.37B(-4.6%) |
| Sep 2005 | - | $3.55B(+9.8%) | $15.06B(-5.5%) |
| Jun 2005 | - | $3.24B(-22.3%) | $15.93B(-2.3%) |
| Mar 2005 | - | $4.17B(+1.7%) | $16.31B(-0.7%) |
| Dec 2004 | $16.43B | $4.10B(-7.3%) | $16.43B(+9.4%) |
| Sep 2004 | - | $4.42B(+22.4%) | $15.01B(+13.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $3.62B(-15.7%) | $13.17B(+15.3%) |
| Mar 2004 | - | $4.29B(+59.9%) | $11.42B(+7.5%) |
| Dec 2003 | $10.37B(-15.2%) | $2.68B(+3.7%) | $10.63B(-8.0%) |
| Sep 2003 | - | $2.59B(+38.6%) | $11.55B(-4.0%) |
| Jun 2003 | - | $1.87B(-46.6%) | $12.03B(-4.8%) |
| Mar 2003 | - | $3.49B(-3.0%) | $12.64B(+3.4%) |
| Dec 2002 | $12.22B(+15.1%) | $3.60B(+17.5%) | $12.22B(+10.7%) |
| Sep 2002 | - | $3.06B(+23.8%) | $11.04B(+2.1%) |
| Jun 2002 | - | $2.48B(-19.5%) | $10.81B(-1.0%) |
| Mar 2002 | - | $3.08B(+27.2%) | $10.92B(+2.7%) |
| Dec 2001 | $10.61B(+23.9%) | $2.42B(-14.8%) | $10.63B(+0.6%) |
| Sep 2001 | - | $2.84B(+9.8%) | $10.56B(+6.0%) |
| Jun 2001 | - | $2.59B(-7.2%) | $9.96B(+7.7%) |
| Mar 2001 | - | $2.79B(+18.5%) | $9.25B(+8.0%) |
| Dec 2000 | $8.57B(+23.1%) | $2.35B(+5.1%) | $8.57B(+5.4%) |
| Sep 2000 | - | $2.24B(+19.4%) | $8.13B(+8.9%) |
| Jun 2000 | - | $1.87B(-11.0%) | $7.47B(+2.0%) |
| Mar 2000 | - | $2.11B(+10.0%) | $7.32B(+14.9%) |
| Dec 1999 | $6.96B(+30.1%) | $1.91B(+21.8%) | $6.37B(-9.0%) |
| Sep 1999 | - | $1.57B(-9.0%) | $7.00B(+9.2%) |
| Jun 1999 | - | $1.73B(+49.5%) | $6.41B(+14.6%) |
| Mar 1999 | - | $1.16B(-54.6%) | $5.59B(+4.5%) |
| Dec 1998 | $5.35B(+74.1%) | $2.54B(+158.8%) | $5.35B(+50.9%) |
| Sep 1998 | - | $983.00M(+7.9%) | $3.54B(+4.6%) |
| Jun 1998 | - | $911.00M(-0.2%) | $3.39B(+6.7%) |
| Mar 1998 | - | $913.00M(+23.7%) | $3.17B(-0.5%) |
| Dec 1997 | $3.07B(+12.0%) | $738.00M(-10.7%) | $3.19B(+9.4%) |
| Sep 1997 | - | $826.00M(+18.5%) | $2.92B(-0.3%) |
| Jun 1997 | - | $697.00M(-25.1%) | $2.93B(+4.4%) |
| Mar 1997 | - | $930.00M(+100.4%) | $2.80B(+4.5%) |
| Dec 1996 | $2.74B(+7.1%) | $464.00M(-44.4%) | $2.68B(-7.3%) |
| Sep 1996 | - | $835.00M(+45.5%) | $2.89B(+5.2%) |
| Jun 1996 | - | $574.00M(-29.0%) | $2.75B(+1.4%) |
| Mar 1996 | - | $809.00M(+20.1%) | $2.71B(+7.0%) |
| Dec 1995 | $2.56B(+29.8%) | $673.80M(-2.5%) | $2.53B(+7.2%) |
| Sep 1995 | - | $691.40M(+28.9%) | $2.36B(+8.5%) |
| Jun 1995 | - | $536.40M(-15.0%) | $2.18B(+6.8%) |
| Mar 1995 | - | $630.90M(+25.5%) | $2.04B(+3.3%) |
| Dec 1994 | $1.97B(+116.0%) | $502.90M(-0.8%) | $1.97B(+75.5%) |
| Sep 1994 | - | $506.90M(+27.6%) | $1.12B(+5.5%) |
| Jun 1994 | - | $397.20M(-29.8%) | $1.07B(-12.8%) |
| Mar 1994 | - | $565.50M(-263.6%) | $1.22B(+6.8%) |
| Dec 1993 | $913.30M(-36.7%) | -$345.60M(-177.1%) | $1.14B(-38.1%) |
| Sep 1993 | - | $448.20M(-19.1%) | $1.85B(+2.5%) |
| Jun 1993 | - | $553.70M(+13.5%) | $1.80B(+18.3%) |
| Mar 1993 | - | $487.80M(+36.6%) | $1.52B(+5.5%) |
| Dec 1992 | $1.44B(+15.1%) | $357.20M(-11.4%) | $1.44B(+7.2%) |
| Sep 1992 | - | $403.00M(+46.9%) | $1.35B(+2.2%) |
| Jun 1992 | - | $274.40M(-32.9%) | $1.32B(+2.2%) |
| Mar 1992 | - | $408.80M(+56.7%) | $1.29B(+2.9%) |
| Dec 1991 | $1.25B(+19.0%) | $260.80M(-30.2%) | $1.25B(+4.2%) |
| Sep 1991 | - | $373.40M(+51.4%) | $1.20B(+3.9%) |
| Jun 1991 | - | $246.60M(-33.8%) | $1.16B(+3.3%) |
| Mar 1991 | - | $372.70M(+77.0%) | $1.12B(+6.4%) |
| Dec 1990 | $1.05B(+8.8%) | $210.60M(-35.9%) | $1.05B(-144.5%) |
| Sep 1990 | - | $328.50M(+57.0%) | -$2.37B(+88.4%) |
| Jun 1990 | - | $209.30M(-31.5%) | -$1.26B(+672.0%) |
| Mar 1990 | - | $305.40M(-109.5%) | -$162.70M(-116.8%) |
| Dec 1989 | $968.20M(-4.3%) | -$3.21B(-323.1%) | $968.20M(-17.4%) |
| Sep 1989 | - | $1.44B(+10.4%) | $1.17B(+5.0%) |
| Jun 1989 | - | $1.30B(-9.3%) | $1.12B(-2.9%) |
| Mar 1989 | - | $1.44B(-147.8%) | $1.15B(+13.7%) |
| Dec 1988 | $1.01B(+7.6%) | -$3.01B(-317.3%) | $1.01B(-23.0%) |
| Sep 1988 | - | $1.38B(+3.5%) | $1.31B(+6.9%) |
| Jun 1988 | - | $1.34B(+3.0%) | $1.23B(+9.8%) |
| Mar 1988 | - | $1.30B(-148.0%) | $1.12B(+19.0%) |
| Dec 1987 | $940.80M(-2.0%) | -$2.70B(-308.3%) | $940.80M(-27.1%) |
| Sep 1987 | - | $1.30B(+5.8%) | $1.29B(+11.7%) |
| Jun 1987 | - | $1.23B(+9.6%) | $1.16B(+10.4%) |
| Mar 1987 | - | $1.12B(-147.6%) | $1.05B(+9.1%) |
| Dec 1986 | $959.70M(+9.1%) | -$2.35B(-302.3%) | $959.70M(-21.8%) |
| Sep 1986 | - | $1.16B(+4.0%) | $1.23B(+14.0%) |
| Jun 1986 | - | $1.12B(+8.3%) | $1.08B(+12.1%) |
| Mar 1986 | - | $1.03B(-149.5%) | $960.20M(+9.9%) |
| Dec 1985 | $880.00M(+5.6%) | -$2.09B(-306.0%) | $873.80M(-3.5%) |
| Sep 1985 | - | $1.01B(+1.1%) | $905.70M(+3.4%) |
| Jun 1985 | - | $1.00B(+5.9%) | $875.60M(+1.9%) |
| Mar 1985 | - | $945.70M(-146.0%) | $859.40M(+3.1%) |
| Dec 1984 | $833.50M | -$2.05B(-309.1%) | $833.50M(-71.1%) |
| Sep 1984 | - | $982.70M(-0.3%) | $2.89B(+51.6%) |
| Jun 1984 | - | $985.70M(+7.2%) | $1.91B(+107.2%) |
| Mar 1984 | - | $919.80M | $919.80M |
FAQ
- What is Pfizer annual earnings before interest & taxes?
- What is the all time high annual EBIT for Pfizer?
- What is Pfizer annual EBIT year-on-year change?
- What is Pfizer quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Pfizer?
- What is Pfizer quarterly EBIT year-on-year change?
- What is Pfizer TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Pfizer?
- What is Pfizer TTM EBIT year-on-year change?
What is Pfizer annual earnings before interest & taxes?
The current annual EBIT of PFE is $11.11B
What is the all time high annual EBIT for Pfizer?
Pfizer all-time high annual earnings before interest & taxes is $35.97B
What is Pfizer annual EBIT year-on-year change?
Over the past year, PFE annual earnings before interest & taxes has changed by +$7.85B (+240.19%)
What is Pfizer quarterly earnings before interest & taxes?
The current quarterly EBIT of PFE is $729.00M
What is the all time high quarterly EBIT for Pfizer?
Pfizer all-time high quarterly earnings before interest & taxes is $11.74B
What is Pfizer quarterly EBIT year-on-year change?
Over the past year, PFE quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Pfizer TTM earnings before interest & taxes?
The current TTM EBIT of PFE is $11.11B
What is the all time high TTM EBIT for Pfizer?
Pfizer all-time high TTM earnings before interest & taxes is $35.97B
What is Pfizer TTM EBIT year-on-year change?
Over the past year, PFE TTM earnings before interest & taxes has changed by $0.00 (0.00%)